abstract |
The invention concerns the use of estrogen receptor (ER) beta -selective agonists for producing a medicine triggering somatropic and/or organotropic effects in the central nervous system, circulatory, skeleton and/or immune system in a male and female aging organism (anti-catabolic therapy). |